Option Care (OPCH) Runs to Near Record on Preliminary FY25 Results

We recently published 10 Stocks Leaving Wall Street in the Dust; 4 Hit Fresh Records. Option Care Health Inc. (NASDAQ:OPCH) was one of the top performers on Tuesday.

Option Care extended gains for a second day on Tuesday, nearly hitting its 52-week high, as investors cheered higher preliminary net revenues for full-year 2025.

At intra-day trading, the stock jumped to as much as $35.47—just 6 cents shy of its 52-week high of $35.53. It trimmed gains at the end of the session to finish the day just up by 8.39 percent at $34.75 apiece.

In a statement, Option Care Health Inc. (NASDAQ:OPCH) said that it is gunning for net revenues between $5.645 billion and $5.655 billion for the said period, or the higher end of its earlier guidance range of $5.60 billion to $5.65 billion.

It also expects to report net income between $59.1 million and $62.4 million, as adjusted diluted earnings per share (EPS) of $1.72 to $1.76, versus its previous guidance of $1.68 to $1.72.

Adjusted EBITDA is targeted at $469 million to $473 million, marking a higher low-end of its previous $468 million to $473 million guidance range.

For the fourth quarter alone, net revenues are targeted at $1.46 billion to $1.47 billion, with net income of $59.1 million to $62.4 million.

Diluted EPS is at $0.37 to $0.39, while adjusted EBITDA is pegged at $123.7 million to $127.7 million.

Official results are scheduled to be released next month, alongside its full-year 2026 financial guidance.

While we acknowledge the potential of OPCH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.